Evidence map›Paper›PMID 42910041›Full record

ArticleFrontiers in pharmacology2026

Quercetin upregulates TLE4 to block the Wnt/β-catenin signaling pathway and inhibit cell migration and invasion of cervical cancer cells.

Yirui Mai, Keyi Ju, Yongkang Yang, Weijing Wang, Ting Zhang, Jiake Wang, Yu Wang, Weihua Gao, Tuanwang Li, Beier Gong and 1 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yirui Mai *The Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
Keyi Ju *The Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
Yongkang Yang *The Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
Weijing WangThe Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
Ting ZhangThe Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
Jiake WangThe Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
Yu WangThe Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
Weihua GaoThe Second Affiliated Hospital, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
Tuanwang LiThe Second Affiliated Hospital, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
Beier GongThe First Clinical Medical College, Yanan University, Yanan City, Shaanxi, China.
Yuanyuan LiThe Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methods: Using established TLE4-overexpression and CRISPR-Cas9-knockout cervical cancer cell lines and nude mouse tumorigenesis models, we verified the biological function and regulatory mechanism of TLE4 in cervical cancer. Results: Quercetin treatment upregulated the expression of TLE4 in HeLa cells. Compared with normal cervical tissues from clinical specimens, the expression of TLE4 in the nucleus of cervical cancer tissues was significantly downregulated. Transwell assays showed that the migration and invasion of C-33A TLE4-overexpression cells were significantly suppressed, accompanied by an upregulation of the expression of E-cadherin and a downregulation of the expression of N-cadherin, Vimentin, and Snail. Conversely, the migration and invasion of Ca Ski TLE4-knockout cells were significantly enhanced, and the expressions of these EMT-related markers showed the opposite trend. Meanwhile, the Conclusion: Quercetin targets and upregulates the expression of TLE4, which inhibits the migration and invasion of cervical cancer cells by blocking the Wnt/β-catenin signaling pathway, thereby providing theoretical and experimental evidence for quercetin therapy in cervical cancer.

Indexed as

cell invasioncell migrationquercetinTLE4Wnt/β-catenin signaling pathway

Identifiers

PMID42910041
PMCPMC13684866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.